Compounds of Formula (I):
wherein R
1
-R
2
, W and Y are as described in the specification,
and their salts and pro-drugs, are inhibitors of DGAT and are thereby useful in the treatment of, for example, obesity. Processes for preparing compounds of formula (I) are also described.
式(I)的化合物:其中R1-R2、W和Y如规范所述,以及它们的盐和前药,是DGAT的
抑制剂,因此在治疗肥胖症等方面是有用的。本文还描述了制备式(I)化合物的过程。